FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382776823> ?p ?o ?g. }

• W4382776823 endingPage "5977" @default.
• W4382776823 startingPage "5967" @default.
• W4382776823 abstract "This study evaluated how daily vitamin C administration impacts systemic oxidative stress and inflammation and its safety in T2D patients. This randomized, double-blinded, placebo-controlled, parallel-arm clinical trial included 70 patients with T2D. They were allocated to receive either 500 mg/day of vitamin C or a matching placebo for 8 weeks. Of the 70 subjects assigned to the trial, 57 were included in the statistical analysis (vitamin C: n = 32, placebo: n = 25). Inflammatory and oxidative markers, including advanced glycation end products (AGEs), malondialdehyde (MDA), advanced oxidation protein products (AOPP), oxidized low-density lipoprotein (ox-LDL), highly sensitive C-reactive protein (hs-CRP), tumor necrosis factor-α (TNF-α), and ferric reducing ability of plasma (FRAP) were measured at baseline and the end of the trial. In addition, vitamin C tolerance was evaluated. A nutritionist visited all participants for a standard diabetic regimen. Following vitamin C supplementation, the serum levels of MDA (p-value < .001) and AGEs (p-value = .002) demonstrated a significant decrease after controlling for multiple confounders, including age, blood pressure, waist circumference, HbA1C, TG, and LDL-C, while no significant changes were observed for AOPP (p-value = .234) and ox-LDL (p-value = .480). The FRAP showed an increasing trend as an antioxidant marker but was not statistically significant (p-value = .312). The hs-CRP and TNF-α had no significant changes (p-value: .899 and .454, respectively). Also, no major adverse events were observed. Vitamin C supplementation may be beneficial in reducing AGEs and MDA in patients with T2D." @default.
• W4382776823 created "2023-07-02" @default.
• W4382776823 creator A5013474288 @default.
• W4382776823 creator A5023368518 @default.
• W4382776823 creator A5049233750 @default.
• W4382776823 creator A5050004970 @default.
• W4382776823 creator A5051311542 @default.
• W4382776823 creator A5059778805 @default.
• W4382776823 creator A5060067672 @default.
• W4382776823 creator A5062813258 @default.
• W4382776823 creator A5088721828 @default.
• W4382776823 creator A5089768281 @default.
• W4382776823 date "2023-06-30" @default.
• W4382776823 modified "2023-10-17" @default.
• W4382776823 title "Vitamin C supplementation lowers advanced glycation end products (<scp>AGEs</scp>) and malondialdehyde (<scp>MDA</scp>) in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled clinical trial" @default.
• W4382776823 cites W1508167383 @default.
• W4382776823 cites W1550111394 @default.
• W4382776823 cites W1658177200 @default.
• W4382776823 cites W181037183 @default.
• W4382776823 cites W1867132694 @default.
• W4382776823 cites W1920382576 @default.
• W4382776823 cites W1956254749 @default.
• W4382776823 cites W1974586446 @default.
• W4382776823 cites W1977829186 @default.
• W4382776823 cites W1994201341 @default.
• W4382776823 cites W2004421102 @default.
• W4382776823 cites W2008126055 @default.
• W4382776823 cites W2013077798 @default.
• W4382776823 cites W2020267609 @default.
• W4382776823 cites W2023863507 @default.
• W4382776823 cites W2025639892 @default.
• W4382776823 cites W2026841676 @default.
• W4382776823 cites W2037141143 @default.
• W4382776823 cites W2045362322 @default.
• W4382776823 cites W2048261702 @default.
• W4382776823 cites W2057453845 @default.
• W4382776823 cites W2075970069 @default.
• W4382776823 cites W2082286023 @default.
• W4382776823 cites W2083990676 @default.
• W4382776823 cites W2098076386 @default.
• W4382776823 cites W2098879265 @default.
• W4382776823 cites W2100322364 @default.
• W4382776823 cites W2110035765 @default.
• W4382776823 cites W2116785215 @default.
• W4382776823 cites W2117809715 @default.
• W4382776823 cites W2122389877 @default.
• W4382776823 cites W2122611065 @default.
• W4382776823 cites W2123560318 @default.
• W4382776823 cites W2139131794 @default.
• W4382776823 cites W2161034584 @default.
• W4382776823 cites W2164023752 @default.
• W4382776823 cites W2165292984 @default.
• W4382776823 cites W2168825044 @default.
• W4382776823 cites W2237224606 @default.
• W4382776823 cites W2290836807 @default.
• W4382776823 cites W2299219980 @default.
• W4382776823 cites W2304950936 @default.
• W4382776823 cites W2410577248 @default.
• W4382776823 cites W2499987376 @default.
• W4382776823 cites W2526958266 @default.
• W4382776823 cites W2558491404 @default.
• W4382776823 cites W2607031541 @default.
• W4382776823 cites W2626441385 @default.
• W4382776823 cites W2737474548 @default.
• W4382776823 cites W2762253115 @default.
• W4382776823 cites W2766820812 @default.
• W4382776823 cites W2771841035 @default.
• W4382776823 cites W2791618216 @default.
• W4382776823 cites W2801193425 @default.
• W4382776823 cites W2945771376 @default.
• W4382776823 cites W2953898551 @default.
• W4382776823 cites W2962872614 @default.
• W4382776823 cites W2997599418 @default.
• W4382776823 cites W3108919522 @default.
• W4382776823 cites W3128426767 @default.
• W4382776823 cites W4235479662 @default.
• W4382776823 cites W4241883936 @default.
• W4382776823 cites W4300695220 @default.
• W4382776823 cites W4302293749 @default.
• W4382776823 cites W4386370474 @default.
• W4382776823 cites W981747777 @default.
• W4382776823 cites W2412442558 @default.
• W4382776823 doi "https://doi.org/10.1002/fsn3.3530" @default.
• W4382776823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37823170" @default.
• W4382776823 hasPublicationYear "2023" @default.
• W4382776823 type Work @default.
• W4382776823 citedByCount "0" @default.
• W4382776823 crossrefType "journal-article" @default.
• W4382776823 hasAuthorship W4382776823A5013474288 @default.
• W4382776823 hasAuthorship W4382776823A5023368518 @default.
• W4382776823 hasAuthorship W4382776823A5049233750 @default.
• W4382776823 hasAuthorship W4382776823A5050004970 @default.
• W4382776823 hasAuthorship W4382776823A5051311542 @default.
• W4382776823 hasAuthorship W4382776823A5059778805 @default.
• W4382776823 hasAuthorship W4382776823A5060067672 @default.
• W4382776823 hasAuthorship W4382776823A5062813258 @default.
• W4382776823 hasAuthorship W4382776823A5088721828 @default.
• W4382776823 hasAuthorship W4382776823A5089768281 @default.

• next